Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China · Delayed Price · Currency is CNY 11.40
0.00 (0.00%)
Apr 10, 2026, 2:45 PM CST
SHE:000590 Revenue
In the year 2025, Guhan Pharmaceutical Group had annual revenue of 337.67M CNY, down -1.61%. Guhan Pharmaceutical Group had revenue of 112.86M in the quarter ending December 31, 2025, a decrease of -11.12%.
Revenue
337.67M
Revenue Growth
-1.61%
P/S Ratio
8.08
Revenue / Employee
291.35K
Employees
1,159
Market Cap
2.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 337.67M | -5.53M | -1.61% |
| Dec 31, 2024 | 343.21M | -61.44M | -15.18% |
| Dec 31, 2023 | 404.65M | 54.12M | 15.44% |
| Jan 1, 2023 | 350.53M | 49.75M | 16.54% |
| Jan 1, 2022 | 300.77M | 25.68M | 9.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 886.96M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Ginwa Enterprise (Group) | 550.44M |
| Chengdu huasun technology group Inc. , LTD. | 545.50M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |